Cao et al. reported that the treatment with UNC0642 decreased the level of histone H3K9me2 and increased the expression of BIM, a proapoptotic protein, in urinary bladder cancer (UBC) cells. This evidence concerns the gene BCL2L11 and urinary bladder cancer.